iSpecimen amends Series C Preferred Stock terms to add anti-dilution adjustment for reverse splits

iSpecimen Inc.

On Jan 16, 2026, iSpecimen filed amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock.
Amendment adjusts Conversion Price and Floor Price proportionately on any reverse stock split or share combination.
Approved by holders of majority of outstanding Series C Preferred Stock per Section 23 of original designation.
No other changes to terms, preferences, or privileges of Series C Preferred Stock.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

iSpecimen Inc.: Filed an Amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock that adjusts Conversion Price and Floor Price proportionately upon reverse stock splits or similar transactions (effective 2026-01-16).

Change: charter amendment
Effective: 2026-01-16

Exact text from the filing

On January 16, 2026, the Company filed an Amended Certificate of Designations, Preferences and Rights of the Series C Convertible Non-Voting Preferred Stock (the “ Amended Certificate of Designation ”) with the Secretary of State of the State of Delaware.

View on SEC.gov

86 governance changes filed in the last 30 days. Browse all governance changes →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-005138

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.